Most strategies for producing pluripotent cells rely on some form of genetic reprogramming or embryonic origin. Dezawa MuseCells® stand apart because they occur naturally in the adult human body, requiring no viral vectors, transcription factor reprogramming, or embryonic tissue. This distinction has driven significant scientific interest, since it addresses two of the longest-standing concerns in stem cell research: tumorigenicity and manufacturing complexity. This article explains the biological basis for that difference and how Muse cells compare to other regenerative cell types currently under investigation.
The Problem Genetic Reprogramming Was Designed to Solve
Induced pluripotent stem cells (iPSCs), first developed by Shinya Yamanaka, are created by introducing specific transcription factors into adult somatic cells to force them back into a pluripotent, embryonic-like state. This approach solved an important ethical and supply problem by removing the need for embryonic tissue, but it introduced new technical challenges, including incomplete reprogramming, genomic instability, and a documented risk of teratoma formation if undifferentiated cells persist after transplantation. Embryonic stem cells (ESCs) carry similar tumorigenicity concerns along with the ethical and regulatory issues tied to embryonic sourcing.
How Muse Cells Occur Naturally Without Reprogramming
Discovery and Identification
Muse cells were first characterized in 2010 by Professor Mari Dezawa and colleagues at Tohoku University. Rather than being engineered, they were discovered as a naturally occurring subpopulation within existing tissue, identified by the surface marker SSEA-3, a marker otherwise associated with pluripotent cells. Muse cells make up a small fraction, typically one to a few percent, of the mesenchymal stem cell population found in bone marrow, adipose tissue, peripheral blood, and connective tissue.
Stress Tolerance as a Defining Trait
The name Muse comes from “multilineage-differentiating stress-enduring” cells, referencing a distinguishing characteristic: these cells survive conditions that kill most other stromal cells, including exposure to trypsin, hypoxia, and serum starvation. This stress tolerance is part of how they were isolated and separated from the broader mesenchymal stem cell population in laboratory settings.
Non-Tumorigenic Behavior in Animal Studies
A central finding across published research is that Muse cells have not been shown to form teratomas in animal models, unlike iPSCs and ESCs. Researchers attribute this to the cells’ more limited and regulated self-renewal activity relative to fully reprogrammed pluripotent cells, even though Muse cells retain the ability to differentiate into cell types representing all three germ layers.
Comparing Muse Cells to Other Regenerative Cell Types Under Investigation
Researchers evaluating cell-based approaches typically weigh several factors when comparing cell types:
- Origin – naturally occurring (Muse cells) versus reprogrammed (iPSCs) versus embryonic (ESCs)
- Tumorigenicity risk – reported absence of teratoma formation in Muse cell animal studies, compared to known risk with iPSCs and ESCs
- Manufacturing complexity – Muse cells do not require reprogramming steps, differentiation induction, or gene editing prior to use
- Immune compatibility – Muse cells express HLA-G, a marker associated with immune tolerance, which researchers have linked to reduced rejection risk without HLA matching or immunosuppression in some studies
- Homing behavior – Muse cells express the S1PR2 receptor, enabling selective migration to injury sites via the sphingosine-1-phosphate (S1P) signaling pathway, a property not shared by standard mesenchymal stem cells to the same degree
Why This Matters for Ongoing Research
The combination of natural origin, non-tumorigenic behavior in models studied to date, and injury-site homing has made Muse cells a distinct subject of study separate from both conventional mesenchymal stem cells and engineered pluripotent cell types. Because no genetic modification step is involved, researchers studying Muse cells are working with a cell population whose behavior is thought to reflect innate biological function rather than an engineered state, which shapes how studies are designed and interpreted across the conditions currently under investigation, including cardiovascular, neurologic, and dermatologic research.
How Isolation and Manufacturing Preserve This Natural State
Sorting Rather Than Engineering
Because Muse cells already exist within tissue such as bone marrow or adipose-derived cell populations, isolating them is a matter of sorting for the SSEA-3 marker rather than inducing a new cellular state. This distinction matters for manufacturing: a sorting-based process is generally more reproducible than a reprogramming-based one, since it does not depend on the efficiency or completeness of an induced transformation.
Why Validation Protocols Still Matter
Even though Muse cells occur naturally, consistent isolation still depends on validated laboratory protocols, including standardized stress-selection steps and marker-based sorting criteria. Variation in these steps between different laboratories or manufacturers can affect the purity and consistency of the resulting cell population, which is why researchers continue to emphasize protocol standardization when comparing results across published studies.
Researchers evaluating a specific Muse cell product for study or trial use typically examine several manufacturing-related factors before drawing conclusions from the associated data:
- Sourcing tissue – bone marrow, adipose tissue, or umbilical cord-derived material, each with distinct isolation considerations
- Marker verification – confirmation of SSEA-3 positivity and stress-tolerance criteria used to define the Muse cell population
- Batch consistency – whether cell yield, viability, and marker expression remain stable across manufacturing batches
- Documentation of validation – whether a given protocol has published, peer-reviewed validation data supporting its isolation method
Frequently Asked Questions
Are Dezawa MuseCells® genetically modified in any way?
No. Muse cells are isolated as a naturally occurring subpopulation of existing stem cells in tissues such as bone marrow and adipose tissue, without reprogramming or gene editing.
How do Muse cells differ from standard mesenchymal stem cells (MSCs)?
Muse cells are a small subset within MSC populations, distinguished by the pluripotent marker SSEA-3, stress tolerance, and an active injury-homing mechanism via the S1P–S1PR2 pathway that is not characteristic of non-Muse MSCs.
Have Muse cells been shown to form tumors?
Published animal studies to date have not demonstrated teratoma formation with Muse cells, in contrast to documented tumorigenicity risk associated with iPSCs and embryonic stem cells.
Why is HLA-G expression significant in Muse cell research?
HLA-G is associated with immune tolerance mechanisms similar to those seen in placental tissue, and researchers have studied whether this allows donor Muse cells to be administered without HLA matching or immunosuppressive drugs in certain trial settings.
The information provided in this article is for educational and informational purposes only and is not intended as medical advice. Treatments and outcomes described may not be appropriate for every individual. Always consult a licensed healthcare provider to determine the best course of care for your specific needs.
Certain regenerative medicine procedures discussed – such as stem cell therapy, exosome therapy, or other biologic treatments – may be considered investigational or not FDA-approved for all conditions. Florida law requires that we disclose this status. While these procedures are offered in accordance with state and federal guidelines, their safety and efficacy have not been fully established by the U.S. Food and Drug Administration.
Results vary, and no guarantee of specific outcome or benefit is implied. All medical procedures involve potential risks, which should be discussed with your treating provider prior to treatment.
© STEMS Health Regenerative Medicine, Miami Beach, Florida. All rights reserved.
